Standardization of Therapeutic Guidelines in Pakistan: The Lack of Considerations and Input from Stakeholders

Abstract

The Standard Treatment Guidelines (STGs) are crucial to evidence-based prophylactic and therapeutic management for safe and effective patient care. To develop or review an STG, a team with all relevant stakeholders should meet regularly to put together all scientifically gathered evidence, analyse the evidence, recommend the STG, and disseminate the guidelines final among the healthcare providers. The following are the key drivers of changes for STGs personalised to local settings: emerging pharmacovigilance data, developing evidence from clinical or pharmacological studies, introducing innovative medicinal agents, etc. Due to genetic and environmental variations, the experts recommend using indigenous evidence from local populations for developing STGs. Alternatively, the international guidelines may be adapted with the necessary modifications and adjustments to cater for the specificities of the local community. Rapid dissemination and effective communication are crucial to help healthcare providers implement the latest STGs in Pakistan.

Keywords

Local evidence, Standard Treatment Guidelines, STG

How to Cite

Hussain, I. M., (2023) “Standardization of Therapeutic Guidelines in Pakistan: The Lack of Considerations and Input from Stakeholders”, British Journal of Pharmacy 8(1). doi: https://doi.org/10.5920/bjpharm.899

528

Views

85

Downloads

Share

Authors

Izhar M. Hussain (Dow University of Health Sciences)

Download

Issue

Dates

Licence

Creative Commons Attribution 4.0

Competing Interests

No conflict of interest in the publication of this article.

Identifiers

Peer Review

This article has been peer reviewed.

File Checksums (MD5)

  • Full text: cad174fbee9c53405f8fb58e65ec1534